Harrenga; Axel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Harrenga; Axel.The latest application filed is for "anti-c4.4a antibodies and uses thereof".

Company Profile

0.8.34

Harrenga; Axel - Wuppertal DE
Harrenga; Axel - DE
Harrenga; Axel - Koln DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Neutralizing prolactin receptor antibody Mat3 and its therapeutic use Grant 9,777,063 - Freiberg , et al. October 3, 2	2017-10-03
Anti-c4.4a Antibodies And Uses Thereof App 20170158775 - LINDEN; Lars ; et al.	2017-06-08
Neutralizing prolactin receptor antibodies and their therapeutic use Grant 9,649,374 - Otto , et al. May 16, 2	2017-05-16
Neutralizing Prolactin Receptor Antibody Mat3 And Its Therapeutic Use App 20160319029 - FREIBERG; Christoph ; et al.	2016-11-03
Anti-tweakr Antibodies And Uses Thereof App 20160237160 - VOTSMEIER; Christian ; et al.	2016-08-18
New Binder-drug Conjugates (adcs) And Use Thereof App 20160193359 - LERCHEN; Hans-Georg ; et al.	2016-07-07
Neutralizing prolactin receptor antibody Mat3 and its therapeutic use Grant 9,353,186 - Freiberg , et al. May 31, 2	2016-05-31
Neutralizing prolactin receptor antibodies and their therapeutic use Grant 9,241,989 - Otto , et al. January 26, 2	2016-01-26
NOVEL BINDER-DRUG CONJUGATES (ADCs) AND USE OF SAME App 20150246136 - LERCHEN; Hans-Georg ; et al.	2015-09-03
Binder-drug conjugates (ADCs) and use thereof Grant 8,992,932 - Lerchen , et al. March 31, 2	2015-03-31
Novel Binder-drug Conjugates (adcs) And Use Thereof App 20150030618 - LERCHEN; Hans-Georg ; et al.	2015-01-29
New Antibody Drug Conjugates (adcs) And The Use Thereof App 20150023989 - Lerchen; Hans-Georg ; et al.	2015-01-22
Anti-FGFR2 Antibodies and Uses Thereof App 20140322220 - Harrenga; Axel ; et al.	2014-10-30
Neutralizing Prolactin Receptor Antibody Mat3 And Its Therapeutic Use App 20140141003 - Freiberg; Christoph ; et al.	2014-05-22
Novel Binder-Drug Conjugates (ADCs) and Use of Same App 20140127240 - Lerchen; Hans-Georg ; et al.	2014-05-08
Binding Proteins To Inhibitors Of Coagulation Factors App 20140050743 - Dittmer; Frank ; et al.	2014-02-20
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use App 20130272968 - Otto; Christiane ; et al.	2013-10-17
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use App 20130171147 - Otto; Christiane ; et al.	2013-07-04
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use App 20130129739 - Ottto; Christiane ; et al.	2013-05-23
New Binder-drug Conjugates (adcs) And Use Thereof App 20130122024 - LERCHEN; Hans-Georg ; et al.	2013-05-16
New binder-drug conjugates (ADCs) and use thereof App 20130095123 - Lerchen; Hans-Georg ; et al.	2013-04-18
New Binder-drug Conjugates (adcs) And Use Thereof App 20130066055 - Lerchen; Hans-Georg ; et al.	2013-03-14
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use App 20130022606 - Otto; Christiane ; et al.	2013-01-24
Anti-c4.4a Antibodies And Uses Thereof App 20120321619 - Linden; Lars ; et al.	2012-12-20
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use App 20120321632 - Otto; Christiane ; et al.	2012-12-20
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use App 20120315276 - Otto; Christiane ; et al.	2012-12-13
Substituted Aminofuranones And Their Use App 20100105673 - Tersteegen; Adrian ; et al.	2010-04-29
Biphenyl Substituted Spirotetronic Acids And Their Use For The Treatment Of Retroviral Diseases App 20100022527 - HEIMBACH; Dirk ; et al.	2010-01-28
Crystal Structure of Enzyme and Uses Thereof App 20100003709 - Reinemer; Peter ; et al.	2010-01-07
Chimeric Kunitz Domains and their Use App 20090170766 - Oehme; Felix ; et al.	2009-07-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.